PHVS: Pharvaris Company Aggregate Debts

Symbol and logo of brand Pharvaris NV (PHVS)

Pharvaris N.V. (PHVS) delegates substance synthesis and clinical trials to external contractors, as it does not own its own manufacturing plants. The company's advantage lies in replacing injections with convenient tablets for the treatment of hereditary angioedema. This chart of share price quotes reflects the dynamics with debt at the level of 0.00. Currently, Pharvaris N.V. (PHVS) operates through the development of scientific projects without generating consistent profit.

PHVS: Pharvaris N.V. Company Debts 07/04/2022 - 10/29/2026

Pharvaris (PHVS) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Price Performance Chart Pharvaris Pharma|PHVS - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Pharvaris Corp|PHVS - Total Company Value
- balance sheet equity data:
Accounting Value of a Share Pharvaris|PHVS - Company Book Value|Market Cap to Net Assets Ratio pharvaris.com|PHVS - Company Total Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Pharvaris N.V.|PHVS - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Pharvaris NV|PHVS - Company Aggregate Debts|Debts to Net Assets Pharvaris Corp|PHVS - Company Long-Term Debt|Company Current Liabilities Pharvaris
General company analysis:PHVS, Pharvaris Pharma
Signature product of Pharvaris NV

The price action of Pharvaris N.V. (PHVS) on this chart reflects the effectiveness of the issuer's financial stability management. Total liabilities capture the market value of aggregate borrowings, excluding reporting lags. This metric sums all short-term and long-term credit liabilities to assess default risk. Debt control is critical for maintaining the costly specialized logistics required for the delivery of orphan drugs. Optimizing this balance ensures uninterrupted patient supply and capital protection.

Competitors of Pharvaris N.V.

ARGX (argenx BVBA) - Aggregate Debt Obligations|Company Aggregate Debts BNTX (BioNTech SE)|Company Aggregate Debts Abivax Corp ABVX|ADMA - Company Debts|Aggregate Debt Obligations PTGX (Protagonist Therapeutics, Inc.)|Immunovant Corp (IMVT) - Company Debts|Company Total Debt Kiniksa Corp|GRFS (Grifols, S.A.) - Company Aggregate Debts|Company Aggregate Debts adaptivebiotech.com|Company Total Debt CLDX (Celldex Therapeutics, Inc.)|AUPH (Aurinia Pharmaceuticals Inc) - Aggregate Debt Obligations|Company Aggregate Debts BCRX (BioCryst Pharmaceuticals Inc)|Company Total Debt Obligations Vera Corp (VERA)|DNTH - Company Debts|AbCellera Biologics Inc (ABCL) - Company Total Debt|Tourmaline Bio (TRML) - Company Debts|Company Total Debt Precigen Inc|Company Total Debt PHAR|Company Aggregate Debts Nektar Corp|Company Debts Upstream Bio Inc (UPB)|zenasbio.com - Company Aggregate Debt|Company Aggregate Debts IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Company Cumulative Debt|KALV - Company Debts|Company Aggregate Indebtedness SEPN|PVLA: Company Aggregate Debts|savarapharma.com - Aggregate Debt Obligations|RIGL (Rigel Pharmaceuticals, Inc.) - Company Aggregate Debts|Company Aggregate Debts AnaptysBio Inc|Company Debts Astria Pharma (ATXS)|ENGN (enGene Corp) - Aggregate Debt Obligations|RAPT Therapeutics - Company Total Debt|Aerovate Therapeutics, Inc. - Company Debts|Aclaris Therapeutics, Inc. - Company Aggregate Debts|KYTX - Company Aggregate Debts|Tiziana Life Sciences PLC (TLSA) - Company Debts|Cabaletta Bio Inc - Aggregate Debt Obligations|VTYX (Ventyx Biosciences) - Company Aggregate Debts|theratech.com (THTX) - Company Total Debt Obligations|Company Debts Avalo Therapeutics (AVTX)|Company Total Debt Obligations Eledon Pharmaceuticals Inc.|Agenus Inc - Company Total Debt|Aggregate Debt Obligations CLYM|ZURA - Company Debts|ATYR (atyrpharma.com) - Company Aggregate Debt|ADAG (adagene.com) - Company Total Debt|IMA - Company Total Debt Obligations|Company Total Debt STTK|Company Debts EQ|Company Total Debt CNTB (Connect Biopharma)|Company Total Debt Obligations immunic-therapeutics.com|Company Debts Atara Bio ATRA|IFRX (InflaRx NV) - Company Aggregate Indebtedness|X4 Pharma - Company Aggregate Debts|Aggregate Debt Obligations ACET (Adicet Bio)|CELU (celularity.com) - Company Total Debt|INMB (inmunebio.com) - Company Debts|Company Debts Barinthus Biotherapeutics plc|Kezar Life Sciences Inc. (KZR) - Company Total Debt Obligations|Company Debts SAB Biotherapeutics, Inc (SABS)|AKTX: Company Aggregate Indebtedness|Company Aggregate Debts ENLV (Enlivex Therapeutics Ltd.)|Aggregate Debt Obligations QTTB|GeoVax - Company Aggregate Debts|EDSA - Company Aggregate Debts|iBio Corp (IBIO) - Company Debts|Carisma Therapeutics Inc. - Aggregate Debt Obligations|Company Debts XTL Biopharmaceuticals|Company Total Debt Bolt Bio (BOLT)|Company Aggregate Debts HCWB|Company Aggregate Debts aptevotherapeutics.com (APVO)|AIM ImmunoTech Inc. - Company Total Debt|Aggregate Debt Obligations ADTX|GRI Bio, Inc. - Company Aggregate Debts|Company Total Debt Obligations xortx.com XRTX|Vyome Holdings (HIND) - Company Debts|Company Total Debt Revelation Biosciences Inc|Company Debts Indaptus|Company Total Debt BiondVax Pharmaceuticals (SCNI)|Company Total Debt CALI (CalciMedica, Inc.)|Company Aggregate Debts affimed.com (AFMD)|Company Debts Allakos ALLK|HOOK: Company Aggregate Debt|IGM Bio - Company Aggregate Debts|Company Cumulative Debt iTeos Pharma|Ocean Biomedical, Inc. (OCEA) - Company Debts|Company Aggregate Indebtedness TCBP (tcbiopharm.com)|THRD (Third Harmonic Bio, Inc.) - Company Aggregate Debts